Geode Capital Management
MGRX icon

Geode Capital Management’s Mangoceuticals MGRX Stock Holding History

Geode Capital Management’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.4K Sell
156,243
-38,239
-20% -$14.7K ﹤0.01% 4206
2026
Q1 		$70K Buy
194,482
+86,160
+80% +$41.3K ﹤0.01% 4233
2025
Q4 		$80.2K Buy
108,322
+20,348
+23% +$33K ﹤0.01% 4149
2025
Q3 		$193K Buy
87,974
+61,476
+232% +$115K ﹤0.01% 3934
2025
Q2 		$40.3K Buy
26,498
+6,928
+35% +$13K ﹤0.01% 4256
2025
Q1 		$38.2K Buy
19,570
+7,567
+63% +$27.2K ﹤0.01% 4238
2024
Q4 		$29.2K Buy
12,003
+3,248
+37% +$8.51K ﹤0.01% 4331
2024
Q3 		$31K Buy
+8,755
New +$41.3K ﹤0.01% 4351

Other funds holding MGRX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.47B AUM 24.93% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
AG
AmeriFlex Group Las Vegas, Nevada $245M AUM 37.62% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management's MGRX Position: Q2 2026 in Review

Geode Capital Management reduced its Mangoceuticals (MGRX) stake by 20% in Q2 2026, selling an estimated $14.7K and leaving 156,243 shares worth $59.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4206.

Geode Capital Management first reported a position in MGRX in Q3 2024 and has held it in 8 quarters since. The position peaked at $193K in Q3 2025. 12 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

  • Geode Capital Management held 156,243 shares of Mangoceuticals worth $59.4K as of Q2 2026.
  • Geode Capital Management sold 38,239 Mangoceuticals shares in Q2 2026, an estimated $14.7K.
  • Mangoceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4206 holding.
  • Geode Capital Management first reported a position in Mangoceuticals in Q3 2024 and has held it in 8 quarters since.
  • Geode Capital Management's Mangoceuticals position peaked at $193K in Q3 2025.
  • 12 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.